Volume 3.13 | Apr 5

Mesenchymal Cell News 3.13, April 5, 2011.
     In this issue: Science News | Current Publications | Industry News | Policy News | Events

Bone Marrow Mesenchymal Stem and Progenitor Cells Induce Monocyte Emigration in Response to Circulating Toll-like Receptor Ligands
Researchers demonstrated that low concentrations of Toll-like receptor ligands in the bloodstream drive CCR2-dependent emigration of
monocytes from bone marrow. [Immunity]



3D Lab Experiments Aid Adult Stem Cell Versatility
A researcher’s experiments hope to recreate the microscopic 3D environment that stem cells would normally occupy inside our bodies and so give an accurate approximation of the factors that might influence the ability of mesenchymal stem cells to eventually produce different types of cell for regenerative medicine. [Press release from the University of York discussing research presented at the UK National Stem Cell Network 2011 Annual Science Conference]


CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal)

Potent Inhibition of Heterotopic Ossification by Nuclear Retinoic Acid Receptor-γ Agonists
Here researchers show that heterotopic ossification was essentially prevented in mice receiving a nuclear retinoic acid receptor-γ (RAR-γ)
agonist. Side effects were minimal, and there was no significant rebound effect. To uncover the mechanisms of these responses, researchers treated mouse mesenchymal stem cells with an RAR-γ agonist and transplanted them into nude mice. [Nat Med]

pH-Controlled Recovery of Placenta-Derived Mesenchymal Stem Cell Sheets
In this study a novel polyelectrolyte-based platform for the engineering and controllable detachment of human mesenchymal stem cell sheets is
presented. [Biomaterials] 

AAV-Mediated Gene Targeting Methods for Human Cells
Here researchers provide a detailed protocol for gene targeting in human cells with AAV vectors. Researchers describe methods for vector
design, stock preparation and titration. Optimized transduction protocols are provided for human pluripotent stem cells, mesenchymal stem cells, fibroblasts and transformed cell lines, as well as a method for identifying targeted clones by Southern blots. [Nat Protoc]

Comparative Assessment of the Effects of Gender-Specific Heparan Sulfates on Mesenchymal Stem Cells
The present study demonstrates the potential usefulness of gender-specific liver heparan sulfate for the manipulation of human mesenchymal
cell properties, including expansion, multipotentiality and subsequent matrix mineralization. [J Biol Chem]

Artificial Niche Combining Elastomeric Substrate and Platelets Guides Vascular Differentiation of Bone Marrow Mononuclear Cells
In this study, researchers hypothesize that an elastomeric scaffold with adsorbed plasma proteins and platelets will induce differentiation
of bone marrow mononuclear cells to vascular cells and promote vascular tissue formation by combining soft tissue mechanical properties with platelet-mediated tissue repairing signals. [Tissue Eng Part A]

Release of Bioactive Adeno-Associated Virus from Fibrin Scaffolds: Effects of Fibrin Glue Concentration
This study showing improved release, transduction efficiency and chondrogenic effect on human mesenchymal stem cells of bioactive AAV-TGF-ß1
released from dilute-fibrin glue provides information important to optimization of this clinically available scaffold for therapeutic gene-delivery, both in cartilage regeneration and for other tissue-engineering applications. [Tissue Eng Part A]

Expansion of the Human Adipose-derived Stromal Vascular Cell Fraction Yields a Population of Smooth Muscle-like Cells with Markedly Distinct Phenotypic and Functional Properties Relative to Mesenchymal Stem Cells
In this study, researchers expanded the stromal vascular fraction of human adipose tissue and characterized the resulting adherent primary cell cultures by quantitative reverse transcription polymerase chain reaction, antigen expression, protein fingerprinting, growth kinetics, in vitro tri-lineage differentiation bioactivity and functional responses to small molecules modulating smooth muscle cell related developmental pathways and compared the results to those obtained with functionally validated mesenchymal stem cell cultures. [Tissue Eng Part C Methods]

Mesenchymal-Like Stem Cells Derived from Human Parthenogenetic Embryonic Stem Cells
The aim of this study was to determine whether human parthenogenetic embryonic stem cells could be differentiated into multipotent
mesenchymal stem cell (MSC)-like cells in vitro, and then compare these cells with those derived from human embryonic stem cells. [Stem Cells Dev]

Tumoricidal Bystander Effect in the Suicide Gene Therapy Using Mesenchymal Stem Cells Does Not Injure Normal Brain Tissues
In the present study, effect of the “bystander effect” associated with the MSCtk/GCV strategy on the background normal brain tissues was
examined in both in vitro and in vivo conditions. [Cancer Lett]

Gas7 Mediates the Differentiation of Human Bone Marrow-Derived Mesenchymal Stem Cells into Functional Osteoblasts by Enhancing Runx2-Dependent Gene Expression
In the present study, researchers found that growth-arrest specific gene 7b (Gas7b) was up-regulated during dexamethasone-induced differentiation of human mesenchymal stem cells into osteoblasts. [J Orthop Res]


Walk Away With a RoboSep™ Facebook Photo Contest Winners
STEMCELL Technologies has announced the Grand Prize Winner and Finalists of the “Walk Away With A RoboSep™” Facebook photo contest. [STEMCELL Technologies Inc. Press Release]

Mount Sinai Hospital Opens New Centre for Regenerative Medicine
Mount Sinai Hospital’s internationally respected Samuel Lunenfeld Research Institute today announced the opening of a new Centre for Regenerative Medicine and Musculoskeletal Research at 25 Orde Street. [Mount Sinai Hospital Press Release]


National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)


NEW Bio International Convention
June 27-30, 2011
Washington, United States

Visit our events page to see a complete list of events in the mesenchymal cell community.


Lab Technologist – Human Embryonic and Induced Pluripotent Stem Cells (STEMCELL Technologies)

Assistant Professor (University of Pittsburgh School of Medicine, Center for Cellular and Molecular Engineering)

Field Applications Specialist – Cell Therapy (Pall Corporation) 

Implementation Coordinator – Maternity Leave Contract (STEMSOFT Software Inc.)

Assistant Professor/Tissue Engineer (The University of Texas Medical School at Houston)

Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization’s career opportunities with the Connexon Creative Job Board at no cost.

Visit here to post your career opportunities.

Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit!

Comments or Suggestions? Email [email protected] with your feedback.

Learn more about Mesenchymal Cell News: Archives | Events | Contact Us